13F Pro13F Pro

NAN FUNG TRINITY (HK) Ltd

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1781880
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare34.0%$344.2M
  • Technology13.5%$136.6M
  • Materials13.2%$133.4M
  • Consumer Discretionary11.8%$119.6M
  • Other11.7%$118.8M
  • Communication Services7.6%$76.6M
  • Real Estate4.5%$45.5M
  • Industrials2.4%$24.5M
  • Financials1.3%$13.5M

AUM History

13fpro.ai/research/fund/nan-fung-trinity-hk-ltd-1781880

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/nan-fung-trinity-hk-ltd-1781880

NAN FUNG TRINITY (HK) Ltd 13F holdings — Q2 2026

$1.0B portfolio (+11.2% QoQ) · 55 holdings · Q2 2026 13F · top 10 are 41% of the stock portfolio

All holdings — NAN FUNG TRINITY (HK) Ltd (Q2 2026)

55 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
UNH$UNHUNITEDHEALTH GROUP INC$28.4M-34%
APD$APDAir Products & Chemicals, Inc.$28.3M—
— ISHARES TR - CORE S&P MCP ETFetf/fund$27.7M—
AMX$AMXAMERICA MOVIL SAB DE CV/adr$27.4M-20%
MIRM$MIRMMirum Pharmaceuticals, Inc.$27.2M—
DHR$DHRDANAHER CORP /DE/$24.1M+28%
TRVI$TRVITrevi Therapeutics, Inc.$22.6M+6%
META$METAMeta Platforms, Inc.$21.0M+146%
PTGX$PTGXProtagonist Therapeutics, Inc$19.7M—
ABVX$ABVXAbivax S.A.adr$18.9M+10%
— SPDR SERIES TRUST - ST STR SP HOMEetf/fund$17.9M—
JD$JDJD.com, Inc.adr$16.6M—
BBIO$BBIOBridgeBio Pharma, Inc.$16.3M—
MP$MPMP Materials Corp. / DE$15.9M—
PDD$PDDPDD Holdings Inc.adr$15.8M+36%

What changed in Q2 2026

Against the previous quarter's 13F: 6 new, 13 added to, 7 trimmed, 13 sold out. Share-count changes; largest moves by dollar size first.

New positions (6)

  • IREN$IRENIREN Ltd$13.5M

    first bought this quarter

  • HONA$HONAHoneywell Aerospace Inc.$12.2M

    first bought this quarter

  • VOR$VORVor Biopharma Inc.$11.9M

    first bought this quarter

  • FLEX$FLEXFLEX LTD.$11.7M

    first bought this quarter

  • CRH$CRHCRH PUBLIC LTD CO$11.4M

    first bought this quarter

  • BCRX$BCRXBIOCRYST PHARMACEUTICALS INC$4.5M

    first bought this quarter

Added to (13)

  • GEHC$GEHCGE HealthCare Technologies Inc.+203%

    now $40.9M · held 4 qtrs

  • META$METAMeta Platforms, Inc.+146%

    now $21.0M · held 3 qtrs

  • HD$HDHOME DEPOT, INC.+37%

    now $35.2M · held 3 qtrs, 3 adds in a row

  • ISHARES TR - MSCI INDONIA ETF+33%

    now $33.7M

  • OC$OCOwens Corning+37%

    now $29.6M · held 2 qtrs, 2 adds in a row

  • DHR$DHRDANAHER CORP /DE/+28%

    now $24.1M · held 4 qtrs

+7 more in the Excel export

Trimmed (7)

  • AMD$AMDADVANCED MICRO DEVICES INC-28%

    now $67.8M · held 4 qtrs

  • UNH$UNHUNITEDHEALTH GROUP INC-34%

    now $28.4M · held 3 qtrs

  • NVDA$NVDANVIDIA CORP-22%

    now $36.1M · held 6 qtrs

  • AMX$AMXAMERICA MOVIL SAB DE CV/-20%

    now $27.4M · held 5 qtrs, 2 trims in a row

  • HON$HONHONEYWELL INTERNATIONAL INC-34%

    now $12.3M · held 6 qtrs

  • CLYM$CLYMClimb Bio, Inc.-14%

    now $4.7M · held 5 qtrs, 2 trims in a row

+1 more in the Excel export

Sold out (13)

  • ISHARES INCwas $35.4M
  • PINS$PINSPINTEREST, INC.was $12.1M

    held 1 qtr

  • TGT$TGTTARGET CORPwas $11.7M

    held 5 qtrs

  • MCHP$MCHPMICROCHIP TECHNOLOGY INCwas $11.0M

    held 1 qtr

  • ORCL$ORCLORACLE CORPwas $9.7M
  • AKR$AKRACADIA REALTY TRUSTwas $8.8M

+7 more in the Excel export

Share

Holdings by quarter

Every 13F NAN FUNG TRINITY (HK) Ltd has filed, 26 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow NAN FUNG TRINITY (HK) Ltd?

Q2 2026 13F filed with the SEC on Jul 24, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of NAN FUNG TRINITY (HK) Ltd's top 20 holdings: 60/100 (our AI quality score, weighted by position size; 14 of the 20 are scored)

Top 10 since filing

-0.0%

Value-weighted move of the 10 largest stock positions

Turnover

16%

Last quarter; 61% over the last 4

Top 10 weight

41%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

67%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

NAN FUNG TRINITY (HK) Ltd disclosed 55 positions worth $1.0B in its Form 13F-HR for Q2 2026, led by $AMD (ADVANCED MICRO DEVICES INC) at 6.7% of the equity portfolio, followed by $AMCR and $PPG. During the quarter the fund opened 6 new positions and exited 13 — including a new stake in $IREN. The portfolio is most concentrated in Healthcare (34.0% of disclosed assets). All figures are sourced directly from NAN FUNG TRINITY (HK) Ltd’s Form 13F-HR filing with the SEC under CIK 1781880.

Funds like this

managers whose biggest positions overlap NAN FUNG TRINITY (HK) Ltd's
Frazier Life Sciences Management, L.P.$4.59B 13F book · 5 shared top holdingsMIRMTRVIBBIOSVRAFirst Turn Management, LLC$934.72M 13F book · 7 shared top holdingsMIRMABVXBBIOXENETCG Crossover Management, LLC$4.16B 13F book · 4 shared top holdingsMIRMABVXVORSVRASILVERARC CAPITAL MANAGEMENT, LLC$962.15M 13F book · 7 shared top holdingsABVXIMNMTRVIXENEThird Point LLC$4.68B 13F book · 4 shared top holdingsDHRWBDFLEXCRHVestal Point Capital, LP$4.28B 13F book · 5 shared top holdingsABVXBCAXTRVIXENE

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: NAN FUNG TRINITY (HK) Ltd

13F Pro is an AI hedge fund tracker and stock research platform. For NAN FUNG TRINITY (HK) Ltd (SEC CIK: 1781880), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in NAN FUNG TRINITY (HK) Ltd's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.